Results 61 to 68 of about 157 (68)

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Lancet, The, 2014
Edward B Garon, Tudor-Eliade Ciuleanu, Oscar Arrieta   +2 more
exaly  

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus

Journal of Infection, 2016
Elisa Petruccioli, Teresa Chiacchio, Ilaria Pepponi   +2 more
exaly  

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Lancet, The, 2016
Nicolino Ruperto, Angela Pistorio, Sheila Oliveira   +2 more
exaly  

PHONE COUNSELING PLUS MEDICATION HELP EVEN HEAVY SMOKERS QUIT

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting

Journal of Clinical Microbiology, 2017
Hee-Won Moon, Rajiv L Gaur, Madhukar Pai   +2 more
exaly  

Properties of NeoMTA Plus and MTA Plus cements for endodontics

International Endodontic Journal, 2017
F Siboni, Paola Taddei, Carlo Prati
exaly  

Analysis and control of max-plus linear discrete-event systems: An introduction

Discrete Event Dynamic Systems: Theory and Applications, 2019
Bart De Schutter, Ton Van Den Boom, Jia Xu   +2 more
exaly  

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Lancet, The, 2010
Johann S De Bono, Stéphane Oudard, Mustafa Ozguroglu   +2 more
exaly